PMID: 35832567
[8] [9] [10] [11] Although reduced GLP-1 secretion has previously been associated with attenuated incretin effect in patients with type 2 diabetes, further research indicates that GLP-1 secretion in patients with type 2 diabetes does not differ from healthy subjects
Patients who consistently use Wegovy observe enduring weight reductionabout 15% of their body weightand more
Prescribing outside the licensed indications and doses constitutes off-label use, which requires prescribers to document their rationale, obtain informed consent, and provide appropriate monitoring
In the stomach, it slows gastric emptying to moderate nutrient absorption
Rakipovski G, Rolin B, Nohr J, Klewe I, Frederiksen KS, Augustin R, et al